Download PDF
1
/
Pages
Previous article
Go back to website
Next article
If you have problems to see the content please click here
Other users also viewed these articles
Liposomal iron in moderate chronic kidney disease
Enrique Montagud-Marrahi; Pilar Arrizabalaga; Rosa Abellana; Esteban Poch;
Nefrologia (English Version). 2020;40:446-52
Cardiovascular-kidney-metabolic syndrome definition and its role in the prevention, risk staging, and treatment. An opportunity for the Nephrology
Aleix Cases; Jose Jesus Broseta; Maria Marqués; Secundino Cigarrán; Juan Carlos Julián; Roberto Alcázar; Alberto Ortiz;
Nefrologia (English Version). 2024;44:771-83
Evaluation of clinical events and costs associated with the addition of dapagliflozin to chronic kidney disease treatment: Cost offset analysis
Juan Francisco Navarro-González; Alberto Ortiz; Ana Cebrián Cuenca; Lluís Segú; Belén Pimentel; Unai Aranda; Blanca Lopez-Chicheri; Margarita Capel; Elisenda Pomares Mallol; Christian Caudron; Juan José García Sánchez; Roberto Alcázar Arroyo;
Nefrologia (English Version). 2024;44:857-67